Biogen at the brink, Pfizer’s big bet and other takeaways from a quiet JPM

A flurry of licensing deals kept things interesting.

READ MORE

JPMorgan Day 4: Talkspace plots comeback

The digital mental health company hit its share of potholes during 2021.

READ MORE

Medicare price negotiations, cancer care and ‘unintended consequences’

READ MORE

JPMorgan Day 3: Bluebird Bio preps for beti-cel launch

With its sickle-cell gene therapy stalled by FDA, the biotech is building for the potential debut of its one-and-done beta-thalassemia treatment, the CEO said.

READ MORE

Latest News

Events
MM+M’s Women of Distinction
MM+M's newly revamped Women of Distinction offering celebrates the industry’s most successful and respected veteran leaders, while Women to Watch shines a light on its up-and-coming talent. Nominations will remain open until January 5, 2022.
LEARN MORE

Featured Categories

Best Places to Work
In-office for culture and camaraderie. Remote for commute-free comfort. Can the business have its cake and eat it too?
Read the December Issue

From Our Partners

HCP engagement in 2022 — The HLD HCP Communications Report
Partner Content
HCP engagement in 2022 — The HLD HCP Communications Report

Healthlink Dimensions’ 2022 Communications Report — your guide for provider-based insights into HCP marketing outreach as COVID continues to reshape the industry.

Health musings and predictions as we close out 2021
Partner Content
Health musings and predictions as we close out 2021

Kim Johnson, Global CEO of Ogilvy Health, sits down with Steve Madden to share her insights on industry developments and challenges over the past year, as well as some thoughts about the unique opportunities for growth in the coming year.

Are more vaccine options the answer for a pandemic-weary public?
Partner Content
Are more vaccine options the answer for a pandemic-weary public?

For the vaccine hesitant who are still contemplating their first, second or booster doses — or are reluctant to vaccinate their children — perhaps more options would help spur them beyond their hesitations.

Using data signals to understand patient needs
Partner Content
Using data signals to understand patient needs

Patients' needs extend beyond their condition — there are multidimensional people behind each diagnosis searching for answers about their interests, hobbies, emotions, lifestyle choices, and more. Now, more than ever, it’s important to find ways to understand consumers as a whole. We can better reach them — and support them — when we do.